Descriptive Analysis of the Medication Complexity Among Hypertensive Patients in Tertiary Hospital Cardiology Departments in China: A Real‐World Study
Journal of Evidence-Based Medicine · 2026
DOI: 10.1111/jebm.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Evidence-Based Medicine, 2026. Verfasst von Yuxiang Pei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Executive Office, Medical Supplies Center of People's Liberation Army General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Hypertension, Polypharmacy, Cardiology Service, Hospital, Antihypertensive Agents. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Objective
To systematically analyze the comorbidity status, polypharmacy patterns, and potential medication risks among hypertensive patients attending cardiology departments in tertiary hospitals in China based on real‐world outpatient prescription data, providing real‐world evidence to describe the medication complexity in this population.
Methods
A cross‐sectional study design was employed. Prescription data of hypertensive patients from the cardiology outpatient departments of 56 tertiary hospitals in mainland China in 2017 were extracted. Diagnosis data, medication data, potentially inappropriate medication (PIM) and potential drug–drug interactions (pDDI) were analyzed. Continuous variables were compared using t ‑tests or Mann–Whitney U tests and reported as mean ± standard deviation or median (interquarile range). Linear regression assessed age‑related trends in medication counts. All tests were two‑sided with α = 0.05.
Results
83.3% of patients had at least one other comorbid condition. The average number of medications per patient was 7.44 ± 5.98, showing a positive correlation with age. Among elderly patients, 10%–15% were exposed to PIMs, and we identified 12 clinically significant pDDI pairs in the cardiology outpatient prescription scenario.
Conclusions
Multimorbidity and polypharmacy are prevalent among hypertensive patients attending cardiology departments in tertiary hospitals in China. These findings serve as a historical baseline rather than direct clinical guidance. Based on the high prevalence of PIMs in elderly patients and typical clinically significant pDDI identified in this cohort, targeted medication safety strategies (including tailored Medication Therapy Management for multimorbid hypertensive patients and appropriate deprescribing of high‐risk agents in the elderly) are suggested to optimize patient‐centered comorbidity management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Executive Office, Medical Supplies Center of People's Liberation Army General Hospital, Beijing, China.
- School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, China.
Zitieren
APA
Pei, Y., Bian, S., & Wan, K. (2026). Descriptive Analysis of the Medication Complexity Among Hypertensive Patients in Tertiary Hospital Cardiology Departments in China: A Real‐World Study. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70167
Vancouver
Pei Y, Bian S, Wan K. Descriptive Analysis of the Medication Complexity Among Hypertensive Patients in Tertiary Hospital Cardiology Departments in China: A Real‐World Study. Journal of Evidence-Based Medicine. 2026. doi:10.1111/jebm.70167
BibTeX
@article{Pei2026,
author = {Pei, Yuxiang and Bian, Shuhe and Wan, Kun},
title = {Descriptive Analysis of the Medication Complexity Among Hypertensive Patients in Tertiary Hospital Cardiology Departments in China: A Real‐World Study},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
doi = {10.1111/jebm.70167}
}
EUVIMED